Nationwide digital primary care platform linked to lower diabetes costs in Türkiye
A retrospective study of nearly 20,000 Turkish patients found a national digital diabetes platform was associated with lower costs and ...
A retrospective study of nearly 20,000 Turkish patients found a national digital diabetes platform was associated with lower costs and ...
A six-month observational study of 252 patients in Bengaluru found that a single-pill combination of sitagliptin, dapagliflozin and metformin was ...
A randomized controlled trial in Thai adults found that a once-daily low-glycemic diabetes-specific formula added to standard nutrition counseling significantly ...
A review finds that brown fat dysfunction and altered batokine signaling are linked with obesity and type 2 diabetes, while ...
GLP-1 receptor agonists, the blockbuster class of drugs behind medications such as semaglutide and liraglutide, have become famous for reshaping ...
Generic semaglutide is starting to rewrite the economics of type 2 diabetes care in Canada. A new analysis published in ...
Glucagon-like peptide-1 (GLP-1) receptor agonists—widely prescribed for type 2 diabetes and obesity—may carry a small but clinically important safety signal, ...
A groundbreaking retrospective chart review, recently published in the prestigious Journal of Clinical Medicine, reveals compelling real-world evidence that deprescribing ...
Recent research has brought to light the promising therapeutic potentials of an extract derived from Eryngium caucasicum, specifically in the ...
In a groundbreaking study poised to reshape the landscape of type 2 diabetes management, researchers have put current glucose-lowering medications ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine